GlassScriptPhysician profile
Robert Vincent Cerniglia
NPI 1952855439
$4,144.06
in general payments reported to CMS, 2019-2025
17 companies · $1,456 in 2025
The $1,456 reported for 2025 was more than what 94% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $346 · 2023: $1,355 · 2024: $861 · 2025: $1,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,553 · Long Term Medical Supply Or Device Loan: $1,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,553.28 |
| Long Term Medical Supply Or Device Loan | $1,119.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,487.78 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $324.25 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $250.94 | 2023 | Arista Ah Flexitip, Channel Drain |
| W. L. Gore & Associates, INC. | $196.17 | 2024 | Gore Synecor Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Baxter Healthcare | $180.82 | 2024 | Floseal, Tisseel |
| Dilon Technologies, INC. | $152.75 | 2024 | Hemoblast Bellows |
| Baudax Bio INC. | $125.00 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $101.98 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $88.15 | 2022-2025 | Bridion |
| Ethicon US, LLC | $70.76 | 2022-2025 | Vistaseal |
| Smith+Nephew, INC. | $43.15 | 2024 | Renasys Go V2 Home, Pico 14 |
| Takeda Pharmaceuticals U.S.A., INC. | $30.66 | 2023-2025 | Gattex |
| Teleflex LLC | $21.78 | 2024 | Solesta |
| Acera Surgical, INC. | $20.32 | 2025 | Restrata Wound Matrix |
| Boston Scientific Corporation | $17.23 | 2025 | Axonics |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $16.36 | 2024 | Abthera, V.A.C.Ulta |
| Pacira Pharmaceuticals Incorporated | $15.96 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cerniglia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.